InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Wins Major Contract With London Public Transport Operator
July 30, 2025
Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company providing intelligent, rapid, non-invasive testing solutions, secured a major contract with one of London’s largest public transport operators covering 14 sites and more than 4,400 staff. The company’s Intelligent Fingerprinting Drug Screening System will be deployed across a bus network carrying over one million passengers daily […]
InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Announces $3.8 Million Warrant Exercise Agreement
July 28, 2025
Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company developing non-invasive testing solutions, entered into an agreement with several current warrant holders to exercise or prepay certain existing warrants for up to 2,023,228 shares of common stock at a reduced price of $1.90 per share. The transaction is expected to generate approximately $3.8 million in […]
InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Strengthens FDA 510(k) Submission With New Security and Performance Data
July 23, 2025
Intelligent Bio Solutions (NASDAQ: INBS) announced the successful collection of new cybersecurity and performance data to support its upcoming FDA 510(k) resubmission for its Intelligent Fingerprinting Drug Screening System. The company conducted rigorous penetration and electromagnetic compatibility testing, along with advanced sweat quantification using ultra-micro balance technology, to validate system resilience and accuracy. With more […]
InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands Global Reach with SMARTOX Distribution Deal
July 16, 2025
Intelligent Bio Solutions (NASDAQ: INBS), a medical tech firm specializing in non-invasive testing, has signed a global distribution agreement with SMARTOX(R) to introduce the SmarTest Patch drug detection product to markets outside the U.S. and Canada. The SmarTest Patch enables continuous, sweat-based drug monitoring and complements INBS’s fingerprint-based testing already distributed by SMARTOX in the […]
InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands Non-Invasive Drug Testing Portfolio With SmarTest Patch
July 15, 2025
Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company specializing in rapid, non-invasive testing, has added the SmarTest(R) Patch to its product lineup. Developed by SMARTOX(R), the wearable patch enables continuous drug detection via sweat over 7 to 10 days, complementing INBS’s Intelligent Fingerprinting Drug Testing Solution. The discreet, water-resistant, tamper-evident device detects substances such […]
InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) to Present Fingerprint Sweat PK Study at ADLM 2025 Clinical Lab Expo
July 10, 2025
Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company specializing in non-invasive testing solutions, will present its pharmacokinetic (PK) study data at the ADLM 2025 Clinical Lab Expo, held July 27–31 in Chicago. The study demonstrated that fingerprint sweat collected using INBS’s portable Intelligent Fingerprinting Drug Screening System reliably mirrors codeine levels found in blood […]
InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands Fingerprint Drug Testing Across Scandinavia with Spjotgard Partnership
June 25, 2025
Intelligent Bio Solutions (NASDAQ: INBS), a medical technology firm specializing in non-invasive drug screening, reported continued success in its partnership with Spjotgard, a Scandinavian distributor. The collaboration is accelerating adoption of INBS’ fingerprint-based Drug Screening System across Sweden, Norway, and Denmark, with Finland showing rising interest. The technology offers a less invasive, hygienic alternative to […]
InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) to Deploy Fingerprint Drug Testing System Across MWS Sites in Australia
June 18, 2025
Intelligent Bio Solutions (NASDAQ: INBS) announced that Managed Waste Service (MWS), a leading Australian waste management provider, will implement INBS’ Intelligent Fingerprinting Drug Screening System across its New South Wales operations. Covering over 20 remote land clearing and green waste sites, this marks MWS’s first shift to in-house, on-site drug testing for pre-employment, random, and […]
InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) CEO Highlights Fingerprint Drug Testing on BioMedWire Podcast
June 17, 2025
Intelligent Bio Solutions (NASDAQ: INBS) CEO Harry Simeonidis joined the latest episode of The BioMedWire Podcast to discuss the company’s rapid, non-invasive drug screening platform and global expansion strategy. Simeonidis detailed how the company’s fingerprint-based technology detects drug use through sweat, enabling faster and more affordable workplace screening. With current deployments in about 20 countries […]
InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands U.S. Forensic Market Presence Through SMARTOX Partnership
June 11, 2025
Intelligent Bio Solutions (NASDAQ: INBS) reported continued growth in the U.S. Forensic Use Only Market through its strategic alliance with SMARTOX, a Texas-based leader in drug and alcohol screening services. SMARTOX has deployed over 50 INBS Intelligent Fingerprinting Drug Screening Readers and conducted more than 7,000 tests to date—including over 1,500 in 2024—demonstrating rising demand […]
InvestorNewsBreaks – Why Intelligent Bio Solutions Inc. (NASDAQ: INBS) Is ‘One to Watch’
June 6, 2025
Intelligent Bio Solutions (NASDAQ: INBS) is a medical technology company pioneering rapid, non-invasive diagnostics through its proprietary Intelligent Fingerprinting Drug Screening System. INBS was featured in a recent article that reads, “By utilizing fingerprint sweat analysis, the company offers a cost-effective, hygienic solution to detect recent drug use — targeting substances commonly found in workplace […]
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Showcases Portable Drug Testing System at RISE25 as U.S. Expansion Advances
June 6, 2025
Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company specializing in rapid, non-invasive testing solutions, recently attended the RISE25 conference to demonstrate its portable Intelligent Fingerprint Drug Screening System, continuing its push into the U.S. market for rapid, non-invasive screening technologies (https://ibn.fm/1JSTS). The event, held May 28–31 in Florida, attracted over 7,000 professionals from the […]
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Progressing with FDA Clearance for Fingerprint Drug Testing as Global Demand Grows
May 23, 2025
Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company specializing in rapid, non-invasive testing solutions, is preparing for its expected U.S. launch in 2025, as it is progressing through the FDA clearance process for its Intelligent Fingerprinting Drug Screening System. The non-invasive device, which detects recent drug use via fingerprint sweat, is gaining international traction […]
InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) to Showcase Fingerprint Drug Testing at RISE25 Conference
May 22, 2025
Intelligent Bio Solutions (NASDAQ: INBS) announced its participation at the RISE25 conference in Kissimmee, Florida, from May 28 to 31, 2025, where it will support U.S. distribution partner SMARTOX. INBS will demonstrate its Intelligent Fingerprinting Drug Screening System—a non-invasive, rapid test using fingerprint sweat to detect substances like THC, cocaine, methamphetamine, and opiates. With results […]
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Targets Global Sales Growth with Multilingual Digital Rollout
May 20, 2025
Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company specializing in rapid, non-invasive testing solutions, is expanding its international footprint by launching localized websites in Arabic, Italian, and Spanish. The initiative is part of the firm’s strategy to boost commercial activity across high-potential regions with growing demand for workplace safety and compliance solutions (https://ibn.fm/odRAg). The […]
InvestorNewsBreaks – Intelligent Bio Solutions Inc. (Nasdaq: INBS) Expands Remote Workforce Testing with Fingerprint Drug Screening in Australia
May 19, 2025
Intelligent Bio Solutions (Nasdaq: INBS), a medical technology company focused on rapid, non-invasive testing, successfully completed a full workforce drug screening for Barcaldine Regional Council in Queensland, Australia, using its Intelligent Fingerprinting Drug Screening System. Over 160 employees were tested and cleared within 90 minutes, significantly reducing operational disruption compared to traditional methods. The on-site, fingerprint-based […]
InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Surpasses 450 Accounts as Fingerprint Drug Testing Expands Globally
May 15, 2025
Intelligent Bio Solutions (NASDAQ: INBS) reported continued commercial growth, surpassing 450 active accounts with 35 added in fiscal Q3, driven by demand for its rapid, non-invasive fingerprint drug testing system. The company expanded into new sectors including luxury marine, retail, and waste management, while entering remote regions across Europe and Australia. INBS now operates in […]
InvestorNewsBreaks – Intelligent Bio Solutions Inc. (Nasdaq: INBS) Grows Revenue, Cuts Losses in Fiscal Q3 as Cartridge Sales Drive Margins
May 13, 2025
Intelligent Bio Solutions (Nasdaq: INBS), a medical technology company delivering rapid, non-invasive testing solutions, reported a 20% sequential revenue increase to $728,867 in fiscal Q3 2025, driven by growth in cartridge sales, which now account for 58% of total revenue and strengthen its recurring revenue model. Gross profit surged 91% year-over-year to $341,368, while net […]
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Is ‘One to Watch’
May 7, 2025
Intelligent Bio Solutions (NASDAQ: INBS) is a medical technology company pioneering rapid, non-invasive diagnostics through its proprietary Intelligent Fingerprinting Drug Screening System. By utilizing fingerprint sweat analysis, the company offers a cost-effective, hygienic solution to detect recent drug use — targeting substances commonly found in workplace settings such as opiates, cocaine, methamphetamine, and cannabis. This innovative […]
Harry Simeonidis, CEO of Intelligent Bio Solutions Inc. (NASDAQ: INBS), to Present at NobleCon20
November 8, 2024
Intelligent Bio Solutions (NASDAQ: INBS) is leading the way in developing advanced diagnostic technologies. The company will be presenting alongside world-class headliners such as Zack Kass, former Head of Go-To-Market at OpenAI where ChatGPT was created, and “Shark Tank” stars Kevin O’Leary, Robert Herjavec, and Daymond John. Discover how the company is revolutionizing the field with […]